Ashland Inc.




Diversified Chemicals

Market Closed - Nyse 04:00:02 2024-07-23 pm EDT 5-day change 1st Jan Change
97.38 USD +1.14% Intraday chart for Ashland Inc. -0.04% +15.50%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Ashland Gets Fair Wage Network Certification MT
Ashland Inc. Appoints Alessandra Faccin as Senior Vice President and General Manager, Life Sciences, Effective June 10, 2024 CI
Ashland Inc. Appoints Ashish K. Kulkarni as Director CI
Ashland Inc. Expects Impairment Charges for the Third Quarter of Fiscal 2024 CI
Ashland Inc. Authorizes Quarterly Dividend, Payable on June 15, 2024 CI
BMO Capital Adjusts Price Target on Ashland to $105 From $97, Maintains Market Perform Rating MT
Ashland to Sell Nutraceuticals Business to Turnspire Capital MT
Turnspire Capital Partners LLC entered into a definitive agreement nutraceuticals business of Ashland Inc (NYSE: ASH). CI
JPMorgan Adjusts Price Target on Ashland to $90 From $88, Maintains Underweight Rating MT
UBS Adjusts Ashland Price Target to $116 From $114, Maintains Buy Rating MT
Ashland Seeks Bolt-On M&A Opportunities CI
Transcript : Ashland Inc., Q2 2024 Earnings Call, May 01, 2024
Tranche Update on Ashland Inc.'s Equity Buyback Plan announced on June 28, 2023. CI
Ashland Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
Ashland Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024 CI
Ashland Inc. Announces Resignation of Ashok Kalyana as Senior Vice President, and General Manager, Life Sciences and Intermediates, Effective May 10, 2024 CI
Ashland Inc Appoints Scott A. Tozier to its Board of Directors CI
North American Morning Briefing : Big Banks Kick -2- DJ
Wells Fargo Upgrades Ashland to Overweight From Equalweight, Raises Price Target to $112 From $100 MT
Active Energy to abandon flagship project in Maine AN
UBS Adjusts Ashland Price Target to $114 From $105, Maintains Buy Rating MT
North American Morning Briefing : Inflation -2- DJ
Jefferies Upgrades Ashland to Buy From Hold, Adjusts Price Target to $126 From $100 MT
EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up AN
AIM WINNERS & LOSERS: Challenger Energy up on Chevron farm-out deal AN
Chart Ashland Inc.
More charts
Logo Ashland Inc.
Ashland Inc. is a global specialty additives and materials company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The Company's segments include life sciences, personal care, specialty additives and intermediates. The life sciences segment is comprised of pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films and fine chemicals. The personal care segment is comprised of bio functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The specialty additives segment is comprised of rheology and additives serving the architectural coatings, construction, energy, automotive and various industrial markets. Its Intermediates segment is comprised of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
Average target price
Spread / Average Target
  1. Stock Market
  2. Equities
  3. ASH Stock
  4. News Ashland Inc.
  5. JPMorgan Adjusts Price Target on Ashland to $90 From $88, Maintains Underweight Rating